Home
Conditions
Respiratory Tract Infections

Clinical trial condition

Respiratory Tract Infections

Explore clinical trials studying Respiratory Tract Infections. Study availability and eligibility vary by location and protocol.

9,607 public trials 648 recruiting studies

Refine in advanced search Browse all conditions

Respiratory Tract Infections trial results

Completed

Non-inferiority Study of GSK Biologicals' Influenza Vaccine GSK576389A Using Different Formulations

NCT00633074

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: GSK Investigational Site Saku, Estonia

GSK Investigational Site Tallinn, Estonia

GSK Investigational Site Tartu, Estonia

View Trial Details

Completed

Study to Evaluate the Immunogenicity and Safety of a Second Vaccination With the Adjuvanted Influenza Vaccine Candidate

NCT00385840

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: GSK Investigational Site Elverum, Norway

GSK Investigational Site Hamar, Norway

GSK Investigational Site Paradis, Norway

GSK Investigational Site Stavanger, Norway

View Trial Details

Completed

Evaluate Safety and Immunogenicity of GSK Bio's Influenza Vaccine GSK576389A After Repeated Vaccination in Elderly Adults

NCT00538473

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: GSK Investigational Site Ghent, Belgium

View Trial Details

Completed

Study to Demonstrate the Lot-to-lot Consistency and to Evaluate the Safety of an Adjuvanted Influenza Vaccine Candidate

NCT00321763

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: GSK Investigational Site Tartu, Estonia

GSK Investigational Site Caen, France

GSK Investigational Site Gières, France

GSK Investigational Site Lagord, France

View all 46 locations

View Trial Details

Completed

Immunogenicity and Safety Study of a GSK Influenza Vaccine Candidate in Adults.

NCT00714285

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: GSK Investigational Site Hradec Králové, Czechia

View Trial Details

Completed

A Phase 2a to Evaluate the Safety of MEDI8852 in Adults With Uncomplicated Influenza

NCT02603952

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: Research Site Canoga Park, California, United States

Research Site Long Beach, California, United States

Research Site Los Angeles, California, United States

Research Site Upland, California, United States

View all 31 locations

View Trial Details

Completed

Study to Evaluate the Immunogenicity and Safety of 2 Formulations of GlaxoSmithKline (GSK) Biologicals' GSK1247446A Low Dose Influenza Vaccine Candidate

NCT00374842

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: GSK Investigational Site Wilrijk, Belgium

View Trial Details

Completed

Safety and Immune Response Study of GSK Biologicals' Influenza Virus Vaccine 1388442A Compared With Fluarix

NCT00693706

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: GSK Investigational Site Miami, Florida, United States

GSK Investigational Site Lenexa, Kansas, United States

View Trial Details

Completed

Immunogenicity and Safety Study of Allantoic Split Inactivated Seasonal Influenza Vaccine (VSI)

NCT03016143

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: Kazakh National Medical University Almaty, Kazakhstan

View Trial Details

Completed

Immune Response Post Pry Vaccination of 2 Formulations of DTPw-HBV Vaccine Given With Rotavirus Vaccine to Infants

NCT00158756

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +21 more
Locations: GSK Investigational Site Barnaul, Russia

GSK Investigational Site Ivanteevka Moscow Region, Russia

GSK Investigational Site Krasnoyarsk, Russia

GSK Investigational Site Moscow, Russia

View Trial Details

Respiratory Tract Infections

Respiratory Tract Infections trial results

Related conditions